1. The long‐acting anti‐C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab. (19th January 2023) Authors: Sica, Michela; Barone, Federica; Nannelli, Caterina; Ricci, Patrizia; Marano, Luana; De Angioletti, Maria; Di Bona, Eros; Risitano, Antonio M.; Notaro, Rosario Journal: British journal of haematology Issue: Volume 201:Number 1(2023) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗